Guardian Pharmacy Services, Inc.
corporate_fare Company Profile
Guardian Pharmacy Services, Inc. (NYSE:GRDN) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 28 items for GRDN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-01, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for GRDN spans 8-K, 10-Q, DEF 14A, SCHEDULE 13D/A.
Recent high-impact activity:
- Guardian Pharmacy Acquires Nautilus Assets, Expanding LTC Footprint to 14 States
- Guardian Pharmacy Raises 2026 Guidance After Strong Q2, Net Income Surges on Settlement
- Guardian Pharmacy Services Acquires Wellness Concepts, Expanding Virginia Operations
- Guardian Pharmacy Announces Executive Leadership Transition: Co-Founder Retires, CFO Becomes COO, New CFO Appointed
- Guardian Pharmacy Secures $80M Revolver Extension to 2030, Boosting Liquidity
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for GRDN, detected from its recent SEC filings · based on capital-structure filings through 2026-03-19.
Secondary Offering Priced at Discount · Significant Insider Share Sales
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →